Differential oral and gut microbial structure related to systemic metabolism in kidney stone patients
- PMID: 38172428
- DOI: 10.1007/s00345-023-04712-5
Differential oral and gut microbial structure related to systemic metabolism in kidney stone patients
Abstract
Objectives: To investigate the role of the oral and gut microbiome related to systemic metabolism and clinical parameters in various types of kidney stone disease.
Patients and methods: We conducted a case-control study by analyzing 16S rRNA and untargeted metabolomics profiling of 76 fecal, 68 saliva, 73 urine, and 43 serum samples from 76 participants aged 18-75 years old. The participants included 15 patients with uric acid stones, 41 patients with calcium oxalate stones, and 20 healthy controls. Correlations among microbiome, metabolism, and clinical parameters were identified through Spearman's correlation analysis. (Clinical trial No. ChiCTR2200055316).
Results: Patients with uric acid stones exhibited reduced richness and diversity in their microbiome, as well as altered composition in both oral and gut microbiome. Furthermore, their fecal samples showed lower relative abundances of Bacteroides and Lachnospiraceae, while their saliva samples showed higher relative abundances of Porphyromonas and Neisseria. Predicted KEGG metabolism pathways, including amino acid and fatty acid metabolisms, were significantly altered in subjects with uric acid stones. Oral, gut microbiota, and metabolism were also associated with low water intake and urine pH. The area under the curve (AUC) of the specific microbiota and metabolite prediction models was over 0.85.
Conclusion: The structure and composition of the oral and gut microbiome in different types of kidney stone disease, the correlations between oral and gut microbiome, and the associations among oral and gut microbiota, systemic metabolism and clinical parameters imply an important role that the oral and gut microbiome may play in kidney stone disease.
Keywords: 16S rRNA; Oral and gut microbiota; Renal uric acid stone; Untargeted metabolomics.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Moses R, Pais VM Jr, Ursiny M, Prien EL Jr, Miller N, Eisner BH (2015) Changes in stone composition over two decades: evaluation of over 10,000 stone analyses. Urolithiasis 43(2):135–139. https://doi.org/10.1007/s00240-015-0756-6 - DOI - PubMed
-
- Knoll T, Schubert AB, Fahlenkamp D, Leusmann DB, Wendt-Nordahl G, Schubert G (2011) Urolithiasis through the ages: data on more than 200,000 urinary stone analyses. J Urol 185(4):1304–1311. https://doi.org/10.1016/j.juro.2010.11.073 - DOI - PubMed
-
- Alkhunaizi AM (2016) Urinary stones in Eastern Saudi Arabia. Urol Ann 8(1):6–9. https://doi.org/10.4103/0974-7796.164841 - DOI - PubMed - PMC
-
- Zeng G, Mai Z, Xia S, Wang Z, Zhang K, Wang L et al (2017) Prevalence of kidney stones in China: an ultrasonography based cross-sectional study. BJU Int 120(1):109–116. https://doi.org/10.1111/bju.13828 - DOI - PubMed
-
- Fontenelle LF, Sarti TD (2019) Kidney stones: treatment and prevention. Am Fam Physician 99(8):490–496 - PubMed
MeSH terms
Substances
Grants and funding
- No.20Y11904600/Scientifc and Technological Innovative Action Plan from Science and Technology Commission of Shanghai Municipality
- No.23141902100/Scientifc and Technological Innovative Action Plan from Science and Technology Commission of Shanghai Municipality
- 2020PJD046/Shanghai Pujiang Program
- 18sjkjgg13/Science and Technology Commission of Songjiang District
- SHDC22021314-A/Shanghai Municipal Hospital Urology Specialist Alliance
LinkOut - more resources
Full Text Sources